Loading…
image

Report Scope & Overview:

Prosthetic Heart Valve & Artificial Heart Valve Market Overview:
Global Prosthetic Heart Valve & Artificial Heart Valve Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Prosthetic Heart Valve & Artificial Heart Valve Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.
 
Overall, Prosthetic Heart Valve & Artificial Heart Valve market plays a crucial role in helping businesses and organizations make informed decisions based on data-driven insights. As the demand for data-driven decision-making continues to grow, Prosthetic Heart Valve & Artificial Heart Valve market research is expected to experience further growth and innovation in the coming years.

global prosthetic heart valve and artificial heart valve market was experiencing steady growth. Prosthetic heart valves are medical devices used to replace damaged or diseased heart valves, while artificial heart valves are generally used in cases of severe heart valve dysfunction or in patients who are not candidates for traditional prosthetic valves. The market for these devices is driven by factors such as an aging population, increasing prevalence of cardiovascular diseases, and advancements in valve technologies.

DESCIMG1

Key Insights

Valve Types: Prosthetic and artificial heart valves can be classified into mechanical valves and biological valves. Mechanical valves are made from durable materials and typically last longer but require lifelong anticoagulation therapy. Biological valves are made from animal tissues or can be tissue-engineered, and they may not require long-term anticoagulation therapy. Both types have their respective advantages and considerations.

Transcatheter Heart Valves: Transcatheter heart valves are a rapidly growing segment within the market. These valves are minimally invasive and can be implanted using catheter-based procedures, avoiding the need for open-heart surgery. Transcatheter aortic valve replacement (TAVR) is the most common procedure, and it has gained popularity as an alternative to surgical aortic valve replacement (SAVR) in high-risk or inoperable patients.

Increasing Demand: The demand for prosthetic heart valves and artificial heart valves is increasing due to factors such as the growing prevalence of valvular heart diseases, advancements in surgical techniques and technologies, and the rising geriatric population. Additionally, an increased focus on improving patient outcomes and quality of life drives the adoption of these devices.

Regulatory Considerations: The prosthetic heart valve and artificial heart valve market is subject to rigorous regulatory requirements to ensure patient safety and product efficacy. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established guidelines for approval and market access.

Technological Advancements: Technological advancements are driving innovation in the market. This includes the development of newer valve designs, materials, and delivery systems, as well as the integration of imaging and navigational technologies for improved precision and outcomes. Additionally, research is ongoing in the field of tissue engineering to develop bioengineered heart valves.


Market Segmentations:

Global Prosthetic Heart Valve & Artificial Heart Valve Market: By Company
• Edwards Lifesciences Corporation
• Medtronic Plc
• St. Jude Medical Inc.(Abbott Laboratories Company)
• Boston Scientific Corporation
• Livanova Plc
• Symetis
• Jenavalve Technology Inc.
• Cryolife Inc.
• Ttk Healthcare Limited
• Colibri Heart Valve
• Lepu Medical Technology
• Braile Biomédica
• Micro Interventional Devices
• Autotissue Berlin Gmbh
• Comed B.V.
• Meril Life Sciences
• Labcor Laboratório
• HLT Inc.(A Bracco Group Company)
• Medtronic
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Livanova Plc
• St. Jude Medical, Inc.(An Abbott Laboratories Company)
• Symetis Sa
• Jenavalve Technology, Inc.
• Cryolife, Inc.
• TTK Healthcare Limited(A Ttk Group Company)
• Colibri Heart Valve, Llc
• Lepu Medical Technology Co., Ltd.
• Braile Biomédica

Global Prosthetic Heart Valve & Artificial Heart Valve Market: By Type
• Transcatheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve

Global Prosthetic Heart Valve & Artificial Heart Valve Market: By Application
• Rheumatic Heart Disease
• Congenital Heart Disease
• Marfan Syndrome
• Other

Global Prosthetic Heart Valve & Artificial Heart Valve Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Prosthetic Heart Valve & Artificial Heart Valve market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Report Attribute/MetricDetails
Base Year2022
Forecast Period2023-2032
Historical Data2018-2022
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Transcatheter Heart Valve
• Tissue Heart Valve
• Mechanical Heart Valve
By Application• Rheumatic Heart Disease
• Congenital Heart Disease
• Marfan Syndrome
• Other
Key Companies Profiled• Edwards Lifesciences Corporation
• Medtronic Plc
• St. Jude Medical Inc.(Abbott Laboratories Company)
• Boston Scientific Corporation
• Livanova Plc
• Symetis
• Jenavalve Technology Inc.
• Cryolife Inc.
• Ttk Healthcare Limited
• Colibri Heart Valve
• Lepu Medical Technology
• Braile Biomédica
• Micro Interventional Devices
• Autotissue Berlin Gmbh
• Comed B.V.
• Meril Life Sciences
• Labcor Laboratório
• HLT Inc.(A Bracco Group Company)
• Medtronic
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• Livanova Plc
• St. Jude Medical, Inc.(An Abbott Laboratories Company)
• Symetis Sa
• Jenavalve Technology, Inc.
• Cryolife, Inc.
• TTK Healthcare Limited(A Ttk Group Company)
• Colibri Heart Valve, Llc
• Lepu Medical Technology Co., Ltd.
• Braile Biomédica
Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request

Reasons to Purchase Prosthetic Heart Valve & Artificial Heart Valve Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.
Overall, market research reports provide businesses and organizations with valuable information that can help them make informed decisions and stay competitive in their industry. They can provide a solid foundation for business planning, strategy development, and decision-making.

Objectives of Prosthetic Heart Valve & Artificial Heart Valve Market Study:
The objectives of Prosthetic Heart Valve & Artificial Heart Valve market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Prosthetic Heart Valve & Artificial Heart Valve market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.
Overall, the objectives of Prosthetic Heart Valve & Artificial Heart Valve market research report are to provide businesses and organizations with valuable insights and data-driven recommendations that can help them make informed business decisions and stay competitive in their industry.

Frequently Asked Questions

  Prosthetic heart valves and artificial heart valves can be classified into two major types: mechanical valves and biological valves. Mechanical valves are typically made from durable materials such as titanium or pyrolytic carbon. Biological valves, also known as tissue valves, are made from animal tissues or can be tissue-engineered using synthetic materials.

  The growth of the prosthetic heart valve and artificial heart valve market is driven by factors such as the increasing prevalence of valvular heart diseases, advancements in valve technologies, an aging population, the rising demand for minimally invasive procedures, and a focus on improving patient outcomes and quality of life.

  North America traditionally holds the largest market share in the prosthetic heart valve and artificial heart valve market, primarily due to the presence of well-established healthcare infrastructure, high adoption of advanced medical technologies, and a large patient pool. However, the market is also growing in other regions, including Europe, Asia Pacific, and Latin America.

  Prominent players in the prosthetic heart valve and artificial heart valve market include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, LivaNova PLC, Boston Scientific Corporation, CryoLife Inc., and Sorin Group, among others. These companies are engaged in research and development activities, product launches, strategic partnerships, and acquisitions to strengthen their market position.

  Challenges in the prosthetic heart valve and artificial heart valve market include the high cost of valve procedures, limited reimbursement policies, the risk of complications and adverse events associated with valve implantation, the need for lifelong anticoagulation therapy in mechanical valves, and the limited availability of donor tissues for biological valves.

TABLE OF CONTENT

1 Prosthetic Heart Valve & Artificial Heart Valve Market Overview
1.1 Product Overview and Scope of Prosthetic Heart Valve & Artificial Heart Valve
1.2 Prosthetic Heart Valve & Artificial Heart Valve Segment by Type
1.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Market Value Comparison by Type (2023-2029)
1.2.2 Transcatheter Heart Valve
1.2.3 Tissue Heart Valve
1.2.4 Mechanical Heart Valve
1.3 Prosthetic Heart Valve & Artificial Heart Valve Segment by Application
1.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Market Value by Application: (2023-2029)
1.3.2 Rheumatic Heart Disease
1.3.3 Congenital Heart Disease
1.3.4 Marfan Syndrome
1.3.5 Other
1.4 Global Prosthetic Heart Valve & Artificial Heart Valve Market Size Estimates and Forecasts
1.4.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue 2017-2032
1.4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales 2017-2032
1.4.3 Global Prosthetic Heart Valve & Artificial Heart Valve Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Prosthetic Heart Valve & Artificial Heart Valve Market Competition by Manufacturers
2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Manufacturers (2017-2023)
2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Average Price by Manufacturers (2017-2023)
2.4 Global Prosthetic Heart Valve & Artificial Heart Valve Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Prosthetic Heart Valve & Artificial Heart Valve, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prosthetic Heart Valve & Artificial Heart Valve, Product Type & Application
2.7 Prosthetic Heart Valve & Artificial Heart Valve Market Competitive Situation and Trends
2.7.1 Prosthetic Heart Valve & Artificial Heart Valve Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prosthetic Heart Valve & Artificial Heart Valve Players Market Share by Revenue
2.7.3 Global Prosthetic Heart Valve & Artificial Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prosthetic Heart Valve & Artificial Heart Valve Retrospective Market Scenario by Region
3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2017-2032
3.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2017-2023
3.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Region: 2023-2032
3.3 Global Prosthetic Heart Valve & Artificial Heart Valve Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region: 2017-2032
3.3.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region: 2017-2023
3.3.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Region: 2023-2032
3.4 North America Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.4.1 North America Prosthetic Heart Valve & Artificial Heart Valve Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2032)
3.4.3 North America Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.5.1 Europe Prosthetic Heart Valve & Artificial Heart Valve Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2032)
3.5.3 Europe Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.6.1 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2032)
3.6.3 Asia Pacific Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.7.1 Latin America Prosthetic Heart Valve & Artificial Heart Valve Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2032)
3.7.3 Latin America Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Market Facts & Figures by Country
3.8.1 Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Sales by Country (2017-2032)
3.8.3 Middle East and Africa Prosthetic Heart Valve & Artificial Heart Valve Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Type (2017-2032)
4.1.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Type (2017-2023)
4.1.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Type (2023-2032)
4.1.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Type (2017-2032)
4.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Type (2017-2032)
4.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Type (2017-2023)
4.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Type (2023-2032)
4.2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Type (2017-2032)
4.3 Global Prosthetic Heart Valve & Artificial Heart Valve Price by Type (2017-2032)
5 Segment by Application
5.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Application (2017-2032)
5.1.1 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Application (2017-2023)
5.1.2 Global Prosthetic Heart Valve & Artificial Heart Valve Sales by Application (2023-2032)
5.1.3 Global Prosthetic Heart Valve & Artificial Heart Valve Sales Market Share by Application (2017-2032)
5.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Application (2017-2032)
5.2.1 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Application (2017-2023)
5.2.2 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue by Application (2023-2032)
5.2.3 Global Prosthetic Heart Valve & Artificial Heart Valve Revenue Market Share by Application (2017-2032)
5.3 Global Prosthetic Heart Valve & Artificial Heart Valve Price by Application (2017-2032)
6 Key Companies Profiled
6.1 Edwards Lifesciences Corporation
6.1.1 Edwards Lifesciences Corporation Corporation Information
6.1.2 Edwards Lifesciences Corporation Description and Business Overview
6.1.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.1.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.2 Medtronic Plc
6.2.1 Medtronic Plc Corporation Information
6.2.2 Medtronic Plc Description and Business Overview
6.2.3 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Medtronic Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.2.5 Medtronic Plc Recent Developments/Updates
6.3 St. Jude Medical Inc.(Abbott Laboratories Company)
6.3.1 St. Jude Medical Inc.(Abbott Laboratories Company) Corporation Information
6.3.2 St. Jude Medical Inc.(Abbott Laboratories Company) Description and Business Overview
6.3.3 St. Jude Medical Inc.(Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.3.4 St. Jude Medical Inc.(Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.3.5 St. Jude Medical Inc.(Abbott Laboratories Company) Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Corporation Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 Livanova Plc
6.5.1 Livanova Plc Corporation Information
6.5.2 Livanova Plc Description and Business Overview
6.5.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.5.5 Livanova Plc Recent Developments/Updates
6.6 Symetis
6.6.1 Symetis Corporation Information
6.6.2 Symetis Description and Business Overview
6.6.3 Symetis Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Symetis Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.6.5 Symetis Recent Developments/Updates
6.7 Jenavalve Technology Inc.
6.6.1 Jenavalve Technology Inc. Corporation Information
6.6.2 Jenavalve Technology Inc. Description and Business Overview
6.6.3 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Jenavalve Technology Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.7.5 Jenavalve Technology Inc. Recent Developments/Updates
6.8 Cryolife Inc.
6.8.1 Cryolife Inc. Corporation Information
6.8.2 Cryolife Inc. Description and Business Overview
6.8.3 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Cryolife Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.8.5 Cryolife Inc. Recent Developments/Updates
6.9 Ttk Healthcare Limited
6.9.1 Ttk Healthcare Limited Corporation Information
6.9.2 Ttk Healthcare Limited Description and Business Overview
6.9.3 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Ttk Healthcare Limited Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.9.5 Ttk Healthcare Limited Recent Developments/Updates
6.10 Colibri Heart Valve
6.10.1 Colibri Heart Valve Corporation Information
6.10.2 Colibri Heart Valve Description and Business Overview
6.10.3 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.10.4 Colibri Heart Valve Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.10.5 Colibri Heart Valve Recent Developments/Updates
6.11 Lepu Medical Technology
6.11.1 Lepu Medical Technology Corporation Information
6.11.2 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.11.3 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.11.4 Lepu Medical Technology Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.11.5 Lepu Medical Technology Recent Developments/Updates
6.12 Braile Biomédica
6.12.1 Braile Biomédica Corporation Information
6.12.2 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.12.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.12.5 Braile Biomédica Recent Developments/Updates
6.13 Micro Interventional Devices
6.13.1 Micro Interventional Devices Corporation Information
6.13.2 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.13.3 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.13.4 Micro Interventional Devices Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.13.5 Micro Interventional Devices Recent Developments/Updates
6.14 Autotissue Berlin Gmbh
6.14.1 Autotissue Berlin Gmbh Corporation Information
6.14.2 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.14.3 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.14.4 Autotissue Berlin Gmbh Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.14.5 Autotissue Berlin Gmbh Recent Developments/Updates
6.15 Comed B.V.
6.15.1 Comed B.V. Corporation Information
6.15.2 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.15.3 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.15.4 Comed B.V. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.15.5 Comed B.V. Recent Developments/Updates
6.16 Meril Life Sciences
6.16.1 Meril Life Sciences Corporation Information
6.16.2 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.16.3 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.16.4 Meril Life Sciences Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.16.5 Meril Life Sciences Recent Developments/Updates
6.17 Labcor Laboratório
6.17.1 Labcor Laboratório Corporation Information
6.17.2 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.17.3 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.17.4 Labcor Laboratório Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.17.5 Labcor Laboratório Recent Developments/Updates
6.18 HLT Inc.(A Bracco Group Company)
6.18.1 HLT Inc.(A Bracco Group Company) Corporation Information
6.18.2 HLT Inc.(A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.18.3 HLT Inc.(A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.18.4 HLT Inc.(A Bracco Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.18.5 HLT Inc.(A Bracco Group Company) Recent Developments/Updates
6.19 Medtronic
6.19.1 Medtronic Corporation Information
6.19.2 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.19.3 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.19.4 Medtronic Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.19.5 Medtronic Recent Developments/Updates
6.20 Edwards Lifesciences Corporation
6.20.1 Edwards Lifesciences Corporation Corporation Information
6.20.2 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.20.3 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.20.4 Edwards Lifesciences Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.20.5 Edwards Lifesciences Corporation Recent Developments/Updates
6.21 Boston Scientific Corporation
6.21.1 Boston Scientific Corporation Corporation Information
6.21.2 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.21.3 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.21.4 Boston Scientific Corporation Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.21.5 Boston Scientific Corporation Recent Developments/Updates
6.22 Livanova Plc
6.22.1 Livanova Plc Corporation Information
6.22.2 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.22.3 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.22.4 Livanova Plc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.22.5 Livanova Plc Recent Developments/Updates
6.23 St. Jude Medical, Inc.(An Abbott Laboratories Company)
6.23.1 St. Jude Medical, Inc.(An Abbott Laboratories Company) Corporation Information
6.23.2 St. Jude Medical, Inc.(An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.23.3 St. Jude Medical, Inc.(An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.23.4 St. Jude Medical, Inc.(An Abbott Laboratories Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.23.5 St. Jude Medical, Inc.(An Abbott Laboratories Company) Recent Developments/Updates
6.24 Symetis Sa
6.24.1 Symetis Sa Corporation Information
6.24.2 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.24.3 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.24.4 Symetis Sa Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.24.5 Symetis Sa Recent Developments/Updates
6.25 Jenavalve Technology, Inc.
6.25.1 Jenavalve Technology, Inc. Corporation Information
6.25.2 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.25.3 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.25.4 Jenavalve Technology, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.25.5 Jenavalve Technology, Inc. Recent Developments/Updates
6.26 Cryolife, Inc.
6.26.1 Cryolife, Inc. Corporation Information
6.26.2 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.26.3 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.26.4 Cryolife, Inc. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.26.5 Cryolife, Inc. Recent Developments/Updates
6.27 TTK Healthcare Limited(A Ttk Group Company)
6.27.1 TTK Healthcare Limited(A Ttk Group Company) Corporation Information
6.27.2 TTK Healthcare Limited(A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.27.3 TTK Healthcare Limited(A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.27.4 TTK Healthcare Limited(A Ttk Group Company) Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.27.5 TTK Healthcare Limited(A Ttk Group Company) Recent Developments/Updates
6.28 Colibri Heart Valve, Llc
6.28.1 Colibri Heart Valve, Llc Corporation Information
6.28.2 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.28.3 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.28.4 Colibri Heart Valve, Llc Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.28.5 Colibri Heart Valve, Llc Recent Developments/Updates
6.29 Lepu Medical Technology Co., Ltd.
6.29.1 Lepu Medical Technology Co., Ltd. Corporation Information
6.29.2 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.29.3 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.29.4 Lepu Medical Technology Co., Ltd. Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.29.5 Lepu Medical Technology Co., Ltd. Recent Developments/Updates
6.30 Braile Biomédica
6.30.1 Braile Biomédica Corporation Information
6.30.2 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Description and Business Overview
6.30.3 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2023)
6.30.4 Braile Biomédica Prosthetic Heart Valve & Artificial Heart Valve Product Portfolio
6.30.5 Braile Biomédica Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prosthetic Heart Valve & Artificial Heart Valve Industry Chain Analysis
7.2 Prosthetic Heart Valve & Artificial Heart Valve Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prosthetic Heart Valve & Artificial Heart Valve Production Mode & Process
7.4 Prosthetic Heart Valve & Artificial Heart Valve Sales and Marketing
7.4.1 Prosthetic Heart Valve & Artificial Heart Valve Sales Channels
7.4.2 Prosthetic Heart Valve & Artificial Heart Valve Distributors
7.5 Prosthetic Heart Valve & Artificial Heart Valve Customers
8 Prosthetic Heart Valve & Artificial Heart Valve Market Dynamics
8.1 Prosthetic Heart Valve & Artificial Heart Valve Industry Trends
8.2 Prosthetic Heart Valve & Artificial Heart Valve Market Drivers
8.3 Prosthetic Heart Valve & Artificial Heart Valve Market Challenges
8.4 Prosthetic Heart Valve & Artificial Heart Valve Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Edwards Lifesciences Corporation
Medtronic Plc
St. Jude Medical Inc.(Abbott Laboratories Company)
Boston Scientific Corporation
Livanova Plc
Symetis
Jenavalve Technology Inc.
Cryolife Inc.
Ttk Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional Devices
Autotissue Berlin Gmbh
Comed B.V.
Meril Life Sciences
Labcor Laboratório
HLT Inc.(A Bracco Group Company)
Medtronic
Edwards Lifesciences Corporation
Boston Scientific Corporation
Livanova Plc
St. Jude Medical, Inc.(An Abbott Laboratories Company)
Symetis Sa
Jenavalve Technology, Inc.
Cryolife, Inc.
TTK Healthcare Limited(A Ttk Group Company)
Colibri Heart Valve, Llc
Lepu Medical Technology Co., Ltd.
Braile Biomédica

Request Sample